Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Telemonitoring Program With Electronic Alerts to Improve Outcomes in the Vulnerable Phase After Hospitalization for Heart Failure: A Pragmatic Clinical Trial TREAT - Vulnerable HF

NCT05972746 is registered in ClinicalTrials.gov with Instituto Cardiovascular de Buenos Aires as lead sponsor.

NCT NCT05972746
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05972746 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Telemonitoring Program With Electronic Alerts to Improve Outcomes in the Vulnerable Phase After Hospitalization for Heart Failure: A Pragmatic Clinical Trial TREAT - Vulnerable HF
Lead sponsor
Instituto Cardiovascular de Buenos Aires
Phase
Not applicable
Overall status
Unknown status
Start date
October 7, 2022
Completion date
November 7, 2023
Enrollment
110 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute heart failure, heart failure